672 related articles for article (PubMed ID: 30374347)
1. Modulating Iron for Metabolic Support of TB Host Defense.
Phelan JJ; Basdeo SA; Tazoll SC; McGivern S; Saborido JR; Keane J
Front Immunol; 2018; 9():2296. PubMed ID: 30374347
[TBL] [Abstract][Full Text] [Related]
2. Desferrioxamine Supports Metabolic Function in Primary Human Macrophages Infected With
Phelan JJ; McQuaid K; Kenny C; Gogan KM; Cox DJ; Basdeo SA; O'Leary S; Tazoll SC; Ó Maoldomhnaigh C; O'Sullivan MP; O'Neill LA; O'Sullivan MJ; Keane J
Front Immunol; 2020; 11():836. PubMed ID: 32477344
[TBL] [Abstract][Full Text] [Related]
3. Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.
Abreu R; Giri P; Quinn F
Front Immunol; 2020; 11():1553. PubMed ID: 32849525
[TBL] [Abstract][Full Text] [Related]
4. Proteomics of
Hoffmann E; Machelart A; Song OR; Brodin P
Front Immunol; 2018; 9():86. PubMed ID: 29441067
[TBL] [Abstract][Full Text] [Related]
5. Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis.
Guler R; Ozturk M; Sabeel S; Motaung B; Parihar SP; Thienemann F; Brombacher F
Front Immunol; 2021; 12():733853. PubMed ID: 34745105
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Tuberculosis Antimicrobials on the Immunometabolic Profiles of Primary Human Macrophages Stimulated with
Cahill C; Cox DJ; O'Connell F; Basdeo SA; Gogan KM; Ó'Maoldomhnaigh C; O'Sullivan J; Keane J; Phelan JJ
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830070
[TBL] [Abstract][Full Text] [Related]
7. An Interplay Between Autophagy and Immunometabolism for Host Defense Against Mycobacterial Infection.
Paik S; Jo EK
Front Immunol; 2020; 11():603951. PubMed ID: 33262773
[TBL] [Abstract][Full Text] [Related]
8. The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M(IL-4) Macrophages in Response to
Lugo-Villarino G; Troegeler A; Balboa L; Lastrucci C; Duval C; Mercier I; Bénard A; Capilla F; Al Saati T; Poincloux R; Kondova I; Verreck FAW; Cougoule C; Maridonneau-Parini I; Sasiain MDC; Neyrolles O
Front Immunol; 2018; 9():1123. PubMed ID: 29946317
[TBL] [Abstract][Full Text] [Related]
9. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics.
Hawn TR; Shah JA; Kalman D
Immunol Rev; 2015 Mar; 264(1):344-62. PubMed ID: 25703571
[TBL] [Abstract][Full Text] [Related]
10. Immunometabolism during Mycobacterium tuberculosis Infection.
Howard NC; Khader SA
Trends Microbiol; 2020 Oct; 28(10):832-850. PubMed ID: 32409147
[TBL] [Abstract][Full Text] [Related]
11. Targeting immunometabolism in host defence against Mycobacterium tuberculosis.
Sheedy FJ; Divangahi M
Immunology; 2021 Feb; 162(2):145-159. PubMed ID: 33020911
[TBL] [Abstract][Full Text] [Related]
12. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
[TBL] [Abstract][Full Text] [Related]
13. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
Kiran D; Podell BK; Chambers M; Basaraba RJ
Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
[TBL] [Abstract][Full Text] [Related]
14. Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances
Moreira JD; Koch BEV; van Veen S; Walburg KV; Vrieling F; Mara Pinto Dabés Guimarães T; Meijer AH; Spaink HP; Ottenhoff THM; Haks MC; Heemskerk MT
Front Immunol; 2020; 11():36. PubMed ID: 32117228
[TBL] [Abstract][Full Text] [Related]
15. Macrophage defense mechanisms against intracellular bacteria.
Weiss G; Schaible UE
Immunol Rev; 2015 Mar; 264(1):182-203. PubMed ID: 25703560
[TBL] [Abstract][Full Text] [Related]
16. New insights into the evasion of host innate immunity by Mycobacterium tuberculosis.
Chai Q; Wang L; Liu CH; Ge B
Cell Mol Immunol; 2020 Sep; 17(9):901-913. PubMed ID: 32728204
[TBL] [Abstract][Full Text] [Related]
17. Host-Directed Therapeutics as a Novel Approach for Tuberculosis Treatment.
Kim YR; Yang CS
J Microbiol Biotechnol; 2017 Sep; 27(9):1549-1558. PubMed ID: 28683527
[TBL] [Abstract][Full Text] [Related]
18. Host defense mechanisms against Mycobacterium tuberculosis.
Chai Q; Lu Z; Liu CH
Cell Mol Life Sci; 2020 May; 77(10):1859-1878. PubMed ID: 31720742
[TBL] [Abstract][Full Text] [Related]
19. Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?
Park HE; Lee W; Shin MK; Shin SJ
Front Immunol; 2021; 12():703060. PubMed ID: 34262571
[TBL] [Abstract][Full Text] [Related]
20. New approaches to tuberculosis--novel drugs based on drug targets related to toll-like receptors in macrophages.
Tomioka H
Curr Pharm Des; 2014; 20(27):4404-17. PubMed ID: 24245765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
